Levofloxacin is a synthetic fluoroquinolone antibiotic and the optically active S-isomer of ofloxacin, widely used to treat bacterial infections of the respiratory, urinary, and gastrointestinal tracts,… Read more















































Levofloxacin is a synthetic fluoroquinolone antibiotic and the optically active S-isomer of ofloxacin, widely used to treat bacterial infections of the respiratory, urinary, and gastrointestinal tracts, as well as skin and soft tissue structures. By inhibiting bacterial DNA gyrase and topoisomerase IV, it effectively halts DNA replication and cell division. In pharmaceutical research and manufacturing, our Levofloxacin category provides essential reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, synthetic intermediates, and stable isotope-labelled compounds. Laboratories utilize these high-quality materials for precise impurity profiling, method validation, stability studies, and routine quality control. These standards ensure analytical accuracy and regulatory compliance during batch release testing, helping to verify the identity, purity, and potency of the active pharmaceutical ingredient. By providing a reliable benchmark for comparative analysis, these compounds support the integrity of pharmaceutical testing processes from development to final drug production.